- Clinical significance of ASB9 in human colorectal cancer.
Tokuoka M, Miyoshi N, Hitora T, Mimori K, Tanaka F, Shibata K, Ishii H, Sekimoto M, Doki Y, Mori M.
Int J Oncol. 2010 Nov;37(5):1105-11.
- Strong interaction between the effects of alcohol consumption and smoking on oesophageal squamous cell carcinoma among individuals with ADH1B and/or ALDH2 risk alleles.
Tanaka F, Yamamoto K, Suzuki S, Inoue H, Tsurumaru M, Kajiyama Y, Kato H, Igaki H, Furuta K, Fujita H, Tanaka T, Tanaka Y, Kawashima Y, Natsugoe S, Setoyama T, Tokudome S, Mimori K, Haraguchi N, Ishii H, Mori M.
Gut. 2010 Nov;59(11):1457-64. doi: 10.1136/gut.2009.205724. Epub 2010 Sep 9.
- Expression of C4.4A at the invasive front is a novel prognostic marker for disease recurrence of colorectal cancer.
Konishi K, Yamamoto H, Mimori K, Takemasa I, Mizushima T, Ikeda M, Sekimoto M, Matsuura N, Takao T, Doki Y, Mori M.
Cancer Sci. 2010 Oct;101(10):2269-77. doi: 10.1111/j.1349-7006.2010.01674.x. Epub 2010 Sep 1. Erratum in: Cancer Sci. 2010 Nov;101(11):2503.
- Jumonji domain containing 1A is a novel prognostic marker for colorectal cancer: in vivo identification from hypoxic tumor cells.
Uemura M, Yamamoto H, Takemasa I, Mimori K, Hemmi H, Mizushima T, Ikeda M, Sekimoto M, Matsuura N, Doki Y, Mori M.
Clin Cancer Res. 2010 Sep 15;16(18):4636-46. doi: 10.1158/1078-0432.CCR-10-0407. Epub 2010 Sep 7.
- Correlated expression of CD47 and SIRPA in bone marrow and in peripheral blood predicts recurrence in breast cancer patients.
Nagahara M, Mimori K, Kataoka A, Ishii H, Tanaka F, Nakagawa T, Sato T, Ono S, Sugihara K, Mori M.
Clin Cancer Res. 2010 Sep 15;16(18):4625-35. doi: 10.1158/1078-0432.CCR-10-0349. Epub 2010 Aug 12.
- CD13 is a therapeutic target in human liver cancer stem cells.
Haraguchi N, Ishii H, Mimori K, Tanaka F, Ohkuma M, Kim HM, Akita H, Takiuchi D, Hatano H, Nagano H, Barnard GF, Doki Y, Mori M.
J Clin Invest. 2010 Sep;120(9):3326-39. doi: 10.1172/JCI42550. Epub 2010 Aug 9.
- Serum matrix-metalloproteinase-1 is a bona fide prognostic marker for colorectal cancer.
Tahara K, Mimori K, Iinuma H, Iwatsuki M, Yokobori T, Ishii H, Anai H, Kitano S, Mori M.
Ann Surg Oncol. 2010 Dec;17(12):3362-9. doi: 10.1245/s10434-010-1149-2. Epub 2010 Jul 9.
- Abnormal expression of PFDN4 in colorectal cancer: a novel marker for prognosis.
Miyoshi N, Ishii H, Mimori K, Nishida N, Tokuoka M, Akita H, Sekimoto M, Doki Y, Mori M.
Ann Surg Oncol. 2010 Nov;17(11):3030-6. doi: 10.1245/s10434-010-1138-5. Epub 2010 Jun 15.
- Clinical significance of human kallikrein7 gene expression in colorectal cancer.
Inoue Y, Yokobori T, Yokoe T, Toiyama Y, Miki C, Mimori K, Mori M, Kusunoki M.
Ann Surg Oncol. 2010 Nov;17(11):3037-42. doi: 10.1245/s10434-010-1132-y. Epub 2010 Jun 11.
- Clinical significance of stanniocalcin 2 as a prognostic marker in gastric cancer.
Yokobori T, Mimori K, Ishii H, Iwatsuki M, Tanaka F, Kamohara Y, Ieta K, Kita Y, Doki Y, Kuwano H, Mori M.
Ann Surg Oncol. 2010 Oct;17(10):2601-7. doi: 10.1245/s10434-010-1086-0. Epub 2010 Apr 27.
- Clinicopathological and prognostic significance of PDCD4 and microRNA-21 in human gastric cancer.
Motoyama K, Inoue H, Mimori K, Tanaka F, Kojima K, Uetake H, Sugihara K, Mori M.
Int J Oncol. 2010 May;36(5):1089-95.
- The clinical significance of vimentin-expressing gastric cancer cells in bone marrow.
Iwatsuki M, Mimori K, Fukagawa T, Ishii H, Yokobori T, Sasako M, Baba H, Mori M.
Ann Surg Oncol. 2010 Sep;17(9):2526-33. doi: 10.1245/s10434-010-1041-0. Epub 2010 Apr 1.
- FANCD2 mRNA overexpression is a bona fide indicator of lymph node metastasis in human colorectal cancer.
Ozawa H, Iwatsuki M, Mimori K, Sato T, Johansson F, Toh H, Watanabe M, Mori M.
Ann Surg Oncol. 2010 Sep;17(9):2341-8. doi: 10.1245/s10434-010-1002-7. Epub 2010 Mar 26.
- Overexpression of SUGT1 in human colorectal cancer and its clinicopathological significance.
Iwatsuki M, Mimori K, Sato T, Toh H, Yokobori T, Tanaka F, Ishikawa K, Baba H, Mori M.
Int J Oncol. 2010 Mar;36(3):569-75.
- TDGF1 is a novel predictive marker for metachronous metastasis of colorectal cancer.
Miyoshi N, Ishii H, Mimori K, Sekimoto M, Doki Y, Mori M.
Int J Oncol. 2010 Mar;36(3):563-8.
- ATP11A is a novel predictive marker for metachronous metastasis of colorectal cancer.
Miyoshi N, Ishii H, Mimori K, Tanaka F, Nagai K, Uemura M, Sekimoto M, Doki Y, Mori M.
Oncol Rep. 2010 Feb;23(2):505-10.
- SCRN1 is a novel marker for prognosis in colorectal cancer.
Miyoshi N, Ishii H, Mimori K, Sekimoto M, Doki Y, Mori M.
J Surg Oncol. 2010 Feb 1;101(2):156-9. doi: 10.1002/jso.21459.
- TGM2 is a novel marker for prognosis and therapeutic target in colorectal cancer.
Miyoshi N, Ishii H, Mimori K, Tanaka F, Hitora T, Tei M, Sekimoto M, Doki Y, Mori M.
Ann Surg Oncol. 2010 Apr;17(4):967-72. doi: 10.1245/s10434-009-0865-y. Epub 2009 Dec 22.
- Defined factors induce reprogramming of gastrointestinal cancer cells.
Miyoshi N, Ishii H, Nagai K, Hoshino H, Mimori K, Tanaka F, Nagano H, Sekimoto M, Doki Y, Mori M.
Proc Natl Acad Sci U S A. 2010 Jan 5;107(1):40-5. doi: 10.1073/pnas.0912407107. Epub 2009 Dec 14.
- Epithelial-mesenchymal transition in cancer development and its clinical significance.
Iwatsuki M, Mimori K, Yokobori T, Ishi H, Beppu T, Nakamori S, Baba H, Mori M.
Cancer Sci. 2010 Feb;101(2):293-9. doi: 10.1111/j.1349-7006.2009.01419.x. Epub 2009 Oct 28. Review.
- Notch pathway as candidate therapeutic target in Her2/Neu/ErbB2 receptor-negative breast tumors.
Hirose H, Ishii H, Mimori K, Ohta D, Ohkuma M, Tsujii H, Saito T, Sekimoto M, Doki Y, Mori M.
Oncol Rep. 2010 Jan;23(1):35-43.
- Loss of FBXW7, a cell cycle regulating gene, in colorectal cancer: clinical significance.
Iwatsuki M, Mimori K, Ishii H, Yokobori T, Takatsuno Y, Sato T, Toh H, Onoyama I, Nakayama KI, Baba H, Mori M.
Int J Cancer. 2010 Apr 15;126(8):1828-37. doi: 10.1002/ijc.24879.
- Saline replacement after local resection of the breast: a simple technique with good control and improved patient satisfaction.
Tanaka F, Mimori K, Tahara K, Inoue H, Mori M.
Breast Cancer. 2010 Oct;17(4):261-4. doi: 10.1007/s12282-009-0145-5. Epub 2009 Aug 4.
